In view of the high SGLT1 mRNA levels under high glucose and diabetic conditions associated with an increased glucagon release from α-cells, Suga et al. suggested that an elevated SGLT1 expression and activity might represent an etiology of hyperglucagonemia in T2D [141], which needs to be further investigated in future studies. This evidence concerns the gene SLC5A1 and type 2 diabetes mellitus.